Nov 5, 2026, 13:07
Five-Year Outcomes of Hemophilia Gene Therapy – Global Hemophilia Report
Global Hemophilia Report shared a post on LinkedIn:
“Five years after gene therapy, what does sustained factor expression mean for patients with hemophilia?
On the latest Global Hemophilia Report, Dr. Steven Pipe discusses five-year outcomes, including patients managing trauma and undergoing surgery without additional factor replacement.
Listen in for key insights on assessing the durability of gene therapy outcomes.
Guests:
- Steven Pipe, MD – Hematologist, Professor of Pediatrics and Pathology, University of Michigan
- Len Valentino, MD – President, World Federation of Hemophilia USA
- Kenneth Friedman, MD – Senior Medical Director, Hematology, Versiti Blood Center of Wisconsin
Hosted by: Patrick James Lynch.”
Proceed to the video attached to the post.
Stay updated with Hemostasis Today.
-
Nov 5, 2026, 12:59Marius Tanase։ Building Stronger Partnerships for Better Bleeding Disorders Care
-
Nov 5, 2026, 12:43George Giannakoulas: NLR as a Predictor of Outcomes in Acute Coronary Syndromes
-
Nov 5, 2026, 12:31Jessica Kruger: The Educational Potential of Hemophilia Treatment Centers
-
Nov 5, 2026, 12:16Noor Aswad։ 200 Kilometers for a More Inclusive Future
-
Nov 5, 2026, 12:07EHC in Romania – Working Towards Better Patient Care
-
Nov 5, 2026, 11:56Mohamed Magdy: Blood Transfusion Reactions – High-Yield Summary
-
Nov 5, 2026, 09:48Kanza Khan: Hematology and Diagnostic Laboratory Techniques
-
Nov 5, 2026, 09:44Wade Tung: PGY2 Training in THM Prepares the Next Generation of Antithrombotic Experts
-
Nov 5, 2026, 09:13Wolfgang Miesbach: Uncovering the Role of Factor VIII in Endothelial Biology